New Medicines Globally
Every day, medicine access delays cost lives.
Medicine access. Made simple.
We guide you and your physician to safely and legally access a prescription medicine that is not yet approved where you live.
Find the latest medicines in neurology, oncology and rare diseases.
Thousands of patients helped with information and access from 175 countries. Let us help you.
We have received enquiries from patients from all over the world. View our live map to see the countries we have supported with information and access to date.
Latest approved medicines available.
Endometrial Cancer | Jemperli (dostarlimab) by GlaxoSmithKline - Approved by FDA and EMA April 2021.
Diffuse Large B-Cell Lymphoma | Zynlonta (loncastuximab tesirine-lpyl) by ADC Therapeutics - Approved by FDA April 2021.
Duchenne Muscular Dystrophy | Amondys 45 (casimersen) by Sarepta Therapeutics - Approved by FDA February 2021.
Multiple Myeloma | Pepaxto (melphalan flufenamide) by Oncopeptides AB - Approved by FDA February 2021.